ArticleScientific reports2025
Reimagining invasive weeds through a preliminary antibacterial and phytochemical evaluation of Ipomoea purpurea (L.) Roth floral and seed ethereal extracts.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
Plant specialized metabolites have emerged as key targets in natural products research for their broad bioactivities and potential in novel drug discovery, such as antibiotics. Regrettably, the reliance on vegetal sources often raises ecological concerns, prompting a shift toward alternative species with no conservation constraints-among them, the invasive weed Ipomoea purpurea (L.) Roth. With limited studies on I. purpurea non-polar metabolites and easy access to its floral and seed material, this study preliminarily explored the antibacterial activity of its ethereal extracts using agar diffusion and microdilution assays, complemented by phytochemically screening their metabolites through conventional methods (i.e., qualitative tests, TLC) and GC-MS molecular networking. Flower and seed extracts showed distinct antibacterial activity against model Gram-negative (E. coli ATCC 25922) and Gram-positive (S. aureus ATCC 25923) reference strains, with the seed extract notably inhibiting S. aureus (MIC = 193 mg/mL). Both shared key phytochemicals, namely coumarins, phytosterols, and terpenoids. Molecular networking showed alkanes, fatty acids and derivatives, and ethers as dominant metabolites in both extracts, with the seed extract exhibiting a higher haloalkanes, phytosterols, and terpenoid count. Six and eight known antibacterial specialized metabolites were identified in the flower and seed extract, respectively. These findings highlight the phytochemical potential of invasive species like I. purpurea as alternative sources of bioactive compounds.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.